Las terapias CAR-T se consolidan frente al cáncer hematológico
El seguimiento de personas portadoras de clones hematopoyéticos con potencial transformación maligna puede ofrecer granes posibilidades en la prevención del
Leer másEl seguimiento de personas portadoras de clones hematopoyéticos con potencial transformación maligna puede ofrecer granes posibilidades en la prevención del
Leer másLa detección precoz es uno de los factores clave para mejorar la expectativa de vida en este tipo de cáncer
Leer másEste tipo de terapia es la última bala contra los linfomas de Hodgkin Varios investigadores del Hospital San Pau de
Leer másCookie | Duración | Descripción |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |